Company Filing History:
Years Active: 2010
Title: Yehuda Goldgur: Innovator in Peptide Deformylase Research
Introduction
Yehuda Goldgur is a notable inventor based in Fair Lawn, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the design and identification of inhibitors for human peptide deformylase. His work has implications for various therapeutic areas, including anti-bacterial, anti-viral, anti-parasitical, anti-inflammatory, and anti-cancer treatments.
Latest Patents
Yehuda Goldgur holds a patent for a method of inhibitor design and identification using a 3-D structure of human peptide deformylase. The patent provides the three-dimensional structure of the human mitochondrial peptide deformylase (HsPDF) protein, complexed with a binding compound, such as a PDF inhibitor. This crystallographic information is crucial for the identification and development of novel binding compounds that target HsPDF and other members of the PDF family.
Career Highlights
Goldgur is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts his research. His work is instrumental in advancing our understanding of peptide deformylase and its potential as a target for drug development.
Collaborations
Some of his notable coworkers include David A. Scheinberg and Sindy Noemi Escobar-Alvarez. Their collaborative efforts contribute to the innovative research being conducted at the Sloan Kettering Institute.
Conclusion
Yehuda Goldgur's contributions to the field of peptide deformylase research highlight his role as an innovator in biochemistry. His patent and ongoing research efforts pave the way for new therapeutic options in combating various diseases.